Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 502939917

Cayman Chemical BalaglItazon 10mg
SDP

Catalog No. 502939917
Encompass_Preferred

A partial agonist of PPARγ (EC50 = 1.351 μM in a transactivation assay); decreases non-fasting plasma glucose levels in diabetic db/db mice (ED90 = 3 mg/kg per day); decreases plasma levels of insulin and glucose in an oral glucose tolerance test in diet-induced obese rats at 5 and 10 mg/kg per day; in doxorubicin-resistant K562 human myelogenous leukemia cells, it decreases P-gp levels, increases intracellular accumulation of rhodamine 123, and sensitizes cells to doxorubicin at 25 μM

Catalog No. 50-293-9917 Supplier Cayman Chemical Supplier No. 2886610 MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

A partial agonist of PPARγ (EC50 = 1.351 μM in a transactivation assay); decreases non-fasting plasma glucose levels in diabetic db/db mice (ED90 = 3 mg/kg per day); decreases plasma levels of insulin and glucose in an oral glucose tolerance test in diet-induced obese rats at 5 and 10 mg/kg per day; in doxorubicin-resistant K562 human myelogenous leukemia cells, it decreases P-gp levels, increases intracellular accumulation of rhodamine 123, and sensitizes cells to doxorubicin at 25 μM

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.